A new therapeutic approach for the eradication of Helicobacter pylori

被引:0
作者
Bouyssou, Caroline
机构
[1] 19100 Brive
来源
ACTUALITES PHARMACEUTIQUES | 2014年 / 53卷 / 536期
关键词
adverse effect; bismuth therapy; contraindication; eradication; Helicobacter pylori; interaction;
D O I
10.1016/j.actpha.2014.02.026
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
A new therapeutic approach for the eradication of Helicobacter pylori. A new galenic formulation combining, in a single capsule, bismuth, metronidazole and tetracycline was approved for sale in France in 2012. It meets a medical need, offering a new treatment for the eradication of Helicobacter pylori, in response to the evolution of resistance to antibiotics. (C) 2014 Elsevier Masson SAS. All rights reserved
引用
收藏
页码:31 / 35
页数:5
相关论文
共 4 条
[1]  
Agence nationale de securite du medicament et des produits de sante (ANSM), 2012, RAPP PUBL EV PYL 140
[2]  
ANSM, 2012, RES CAR PROD
[3]  
direction de l'evaluation medicale economique et de sante publique, 2012, AV COMM TRANSP PYL 1
[4]  
Lamarque D, 2012, ENTRETIENS BICHAT